Objectives: The aim of this study was to elucidate the role of two novel membrane fusion proteins (MFPs) in the susceptibility of Acinetobacter baumannii to antimicrobial agents.
Introduction
Acinetobacter baumannii is a rapidly emerging nosocomial pathogen that causes severe infections, including bacteraemia, pneumonia, meningitis, urinary tract and wound infections. 1 It has now become a major cause of hospital-acquired infections worldwide due to its remarkable propensity to rapidly acquire resistance determinants to a wide range of antibacterial agents. 2 In bacteria, resistance to antibiotics is often associated with multidrug efflux pumps functioning to decrease cellular drug accumulation. 3 In Gram-negative bacteria, including A. baumannii, the pumps belonging to the resistance nodulation division (RND) family are significantly effective in generating resistance, as they form a tripartite complex together with the periplasmic proteins belonging to the membrane fusion protein (MFP) family and the outer membrane protein (OMP) channels, so that drugs are pumped out directly to the external medium. The RND pumps often have wide substrate specificity. 4 The beststudied members of the RND group are the MexAB-OprM system of Pseudomonas aeruginosa and the AcrAB-TolC system of Escherichia coli, where AcrA and MexA are the MFPs in the system. 5, 6 The RND efflux complex in A. baumannii-AdeI (the MFP), AdeJ (transporter), together with AdeK (OMP)-was found to confer resistance to b-lactams, aminoglycosides, fluoroquinolones and structurally unrelated compounds. 7 The first member of the RND family of exporters discovered in A. baumannii BM4454 was the AdeABC system, and it is known to pump out mostly aminoglycosides, tetracycline, erythromycin and fluoroquinolones. 8 Availability of bacterial genome sequences enable us to trace the presence of putative drug resistance genes in the A. baumannii ATCC 17978 genome. 9 We focused our research efforts on a pair of open reading frames (ORFs) that displayed homologies to known members of the MFP family. Therefore, the aim of the present study was to delineate the functions of 
Materials and methods
Bacterial strains, growth medium and chemicals A. baumannii AC0037, an MDR strain used in this study, was isolated from a patient with a respiratory tract infection in the Ohio State University Medical Center, Columbus, Ohio.
10 E. coli KAM32 (DacrAB DydhE) was used as the host for genetic studies. Bacteria were grown at 378C in LuriaBertani (LB) and agar (Difco Laboratories, Sparks, NV, USA). Antibiotics, dyes, detergents and inhibitors were purchased from Sigma-Aldrich.
Cloning of the putative efflux genes
The genome of A. baumannii ATCC 17978 (accession number CP000521.1) has a pair of ORFs, both annotated as AdeT. 9 The ORF1 (A1S_1755) and ORF2 (A1S_3092) are two separate, distinct and distantly placed putative efflux genes. Genomic DNA from A. baumannii AC0037 was extracted using the DNeasy Tissue Kit (Qiagen, Valencia, CA, USA). These ORFs were amplified from A. baumannii AC0037 using gene-specific primers adeT1F/R and adeT2F/R, as listed in Table 1 , by PCR as described previously 11 with minor modifications. For the sake of this study, ORF1 from A. baumannii AC0037 is designated as AdeT1 and ORF2 is designated as AdeT2. The obtained PCR products were purified by using the QiaQuick PCR Purification Kit (Qiagen), digested with EcoRI and BamHI, and then cloned into pUC18 vector digested with the same enzymes. The recombinant plasmids denoted pAdeT1 and pAdeT2 were transformed into E. coli KAM32 to generate E. coli KAM32/ pAdeT1 and E. coli KAM32/pAdeT2.
MICs
MICs were determined according to the guidelines of the CLSI by the broth dilution method in Mueller-Hinton broth (MHB; Difco Laboratories). 12 The MIC was defined as the lowest drug concentration that prevented visible growth of bacteria. Susceptibility was tested in duplicate, and the tests were repeated three times.
Accumulation studies
Accumulation of ciprofloxacin was monitored as described previously. 13 Briefly, bacteria were grown to log phase, harvested and suspended in PBS to an OD 600 of 0.2. Ciprofloxacin was added to a final concentration of 10 mg/L. Fluorimetric measurements were performed using an LS 55 Fluorescence Spectrometer, 120V (Perkin-Elmer). The assay was also performed using 4
′ ,6-diamidino-2-phenylindole (DAPI). DAPI binds to specific cellular components and undergoes a change in fluorescence that can be used to indicate how much of the substrate is retained by the cell and therefore its accumulation can be used to assess the relative level of active efflux in bacterial cells. 14 The excitation and emission wavelengths used for the fluorescent compounds were as follows: ciprofloxacin, 275/ 440 nm; DAPI, 345/455 nm, respectively.
Construction of deletion mutants in A. baumannii AC0037
To construct an adeT1 defective mutant, 400 bp upstream (amplicon A) with primers UpP1/ParP2 (Table 1 ) and 350 bp downstream with primer ParP3, DwnP4 (amplicon B) was amplified by PCR from A. baumannii AC0037. The products A and B were digested with respective enzymes as present in their primer sequences. The digested PCR fragments were ligated with PstI-kanamycin resistance cassette (K) from the pUC-4K vector. The resulting AKB fragment was inserted into the XbaI and BamHI double-digested plasmid pUC18 (unable to replicate in A. baumannii), 15 generating the padeT1-Kan plasmid. The recombinant plasmid padeT1-Kan was introduced into the kanamycin-susceptible, ticarcillin-resistant A. baumannii AC0037 by electroporation (Eppendorf, Hamburg, Germany). Selection of the adeT1 null mutant was made on plates containing 50 mg/L kanamycin and 80 mg/L tircarcillin and confirmed by DNA sequencing; the mutant was designated as AC0037DadeT1. A similar strategy was used to inactivate adeT2 using primers UpP5 and ParP6 (300 bp) and ParP7 and DwnP8 (250 bp). The adeT2 null mutant was designated AC0037DadeT2.
Complementation studies with AdeT deletion mutants
Briefly, a DNA fragment containing a functional aadA1 gene was amplified from the AC0019 clinical isolate (accession number EU977568.1) by PCR using primers aadA1F/R and was ligated into the E. coli-Acinetobacter shuttle vector pWH1266. 16 The resulting plasmid, pWH-Spc, was modified by cloning a PCR-amplified parental gene adeT1 from A. baumannii strain AC0037 into the PstI site of pWH-Spc to yield a recombinant plasmid pWH-adeT1. Electroporation of the recombinant plasmid pWH-adeT1 into deletion mutant AC0037DadeT1 resulted in an AC0037DadeT1VadeT1 mutant. Selection of the complemented mutant was made on plates containing 200 mg/L streptomycin and 50 mg/L kanamycin. A similar approach was followed to generate AC0037DadeT2 VadeT2.
Data analysis
The assays were performed in triplicate on independent occasions to confirm reproducibility. All data are presented as means + SEM.
Accession numbers for the gene sequences
The nucleotide sequences have been deposited in the GenBank nucleotide sequence database under the accession numbers GQ338837 and GQ338838. 
Results and discussion
Cloning of two putative ORFs from A. baumannii AC0037
The two ORFs annotated as AdeT were amplified by PCR from A. baumannii AC0037 and cloned in pUC18 to yield recombinant plasmids pAdeT1 and pAdeT2. Sequencing revealed that pAdeT1 harboured one complete ORF (100% identical to A1S_1755) and plasmid pAdeT2 harboured the other ORF (100% identical to A1S_3092). Further sequence analysis revealed that adeT1 is a 915 bp gene with a start and stop codon and specifies a 304 amino acid protein with a predicted mass of 33.46 kDa. The adeT2 gene is a 717 bp gene with a start and stop codon and specifies a 238 amino acid protein with a predicted mass of 27.28 kDa. Using the Basic Local Alignment Search Tool (BLAST) at www. ncbi.nlm.nih.gov, it was observed that the AdeTs exhibit .30% similarity to CmeA of Campylobacter jejuni (accession number ACQ85275), 17 MexA of P. aeruginosa (accession number AAG03814) 5 and AdeA of A. baumannii (accession number YP_002319438). 8 Thus, initial assessment indicated 
Contributions of the accessory proteins AdeT1 and AdeT2 in mediating antimicrobial resistance
The MICs of antimicrobial agents for E. coli KAM32 carrying AdeT1 (E. coli KAM32/pAdeT1) and AdeT2 (E. coli KAM32/ pAdeT2) were monitored and compared with the control strain (E. coli KAM32/pUC18) to obtain the fold differences in susceptibilities. Expression of AdeT1 or AdeT2 in E. coli KAM32 from the vector exhibited a similar fold higher resistance to erythromycin (6-and 5-fold, respectively), Acridine Orange (4-and 6-fold, respectively) and DAPI (4-and 4-fold, respectively).
AdeT1-carrying E. coli cells displayed elevated MICs of chloramphenicol (5-fold), novobiocin (5-fold), gentamicin (4-fold), kanamycin (3-fold), acriflavine (4-fold), deoxycholate (4-fold), SDS (4-fold) and benzalkonium chloride (3-fold) ( Table 2 ). AdeT2 also conferred a similar profile of increased MICs ( Table 2) .
Characterization of efflux genes in MDR clinical strain A. baumannii AC0037
To decipher the role of adeT in A. baumannii, AC0037DadeT1 and AC0037DadeT2 mutants were constructed as described in the 'Materials and methods' section. Susceptibility testing was performed with these mutants along with their parental strain AC0037 as control. Data showed that deletion of adeT resulted in increased susceptibility to different antibiotics, dyes, detergents and disinfectants (Table 2) .
Complementation studies
The role of A. baumannii adeTs was confirmed by performing complementation experiments as described in the methodology. The expression of AdeT1 and AdeT2 in complemented strains was confirmed at the RNA level (data not shown). Susceptibility testing indicated that complementation with wild-type gene restored the ability of the deletion mutants to confer resistance to antimicrobial agents similar to that displayed by AC0037 (Table 2 ).
Fluorimetric efflux assay using A. baumannii null mutants
Fluorimetric experimentation was performed to elucidate the participation of adeT in active efflux. The ciprofloxacin accumulation data indicated that efflux was decreased in AC0037DadeT1 compared with the wild-type AC0037, whereas it was increased (.3-fold increased accumulation) in the AC0037DadeT2 mutant. Expression of AdeT2 increased the MIC of ciprofloxacin; upon deleting adeT2 in the native host (AC0037DadeT2 mutant), ciprofloxacin efflux was decreased in the AC0037DadeT2 mutant, which was obvious, as the mutant lacked the functional AdeT2 protein. The addition of CCCP increased the ciprofloxacin accumulation levels, which eventually reached a plateau in the tested strains (Figure 1a) . However, upon inactivating a single gene we did not observe a complete loss in resistance profile. It is worthy to state here that other efflux pumps in the genome of the bacteria have a role in conferring decreased susceptibility to these agents.
An increase in the MIC of DAPI was observed upon expressing either gene in E. coli, thus their absence led to an increased accumulation of DAPI in AC0037DadeT1 (.1.5-fold) and AC0037DadeT2 (.2.3-fold) mutants (Figure 1b) . Data presented here indicate that AdeTs possibly cooperate with other A. baumannii transporters such as AdeB or AdeJ and OMPs such as AdeC or AdeK to mediate the antimicrobial resistance phenomenon.
Conclusions
Overall, using genetic tools, we demonstrated for the first time the importance of two MFPs in mediating antimicrobial resistance in a MDR clinical isolate, A. baumannii AC0037.
